In the quest for alternative markers, previous studies have revealed that the heme protein myeloperoxidase (MPO), released by activated polymorphonuclear neutrophils and to a smaller extent by monocytes, is significantly increased in CHF patients irrespective of the etiology [9]. This evidence concerns the gene MPO and congestive heart failure.